CD40 and neoplasm: For example, the CD40:CD40 ligand interaction tilts the myeloid immune cell population in favor of an anti-tumor instead of an immunosuppressive phenotype, and this is accompanied by an increased level of activated T cells in the tumor tissue, suggesting this interaction as a promising target [124, 142–144].